Skip to content
TrialScanner

NCT03964727

Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors

Phase 2Active, not recruitingGILDLead

Registry record

Lead sponsor
Gilead Sciences
Conditions
Metastatic Solid Tumor
Primary completion
Jan 15, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03964727 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03964727: Study of Sacituzumab... | TrialScanner